FDA approves Elite’s generic Methotrexate
Methotrexate belongs to a class of drugs known as antimetabolites.
Elite, a specialty pharmaceutical company developing niche generic products, has received approval from the Food and Drug Administration for generic Methotrexate Sodium 2.5 mg tablets.
Methotrexate belongs to a class of drugs known as antimetabolites and will be sold under the Elite Laboratories label.
[Read more: Challenges continue, but generics companies see a bright future with biosimilars]
The generic product had a market value of $64.3 million for the 12 months ending March 2024, per IQVIA.
[Read more: Elite Pharmaceuticals files ANDA for generic opiate analgesic product]